Skip to content

Latest medicine updates

50 updates found

New New Updated Updated Retired Retired

NARROW IT DOWN

MEDICINE NAME

CHANGES

Date range

DOCUMENT TYPE

STATUS

Pil
oestrogens, conjugated , bazedoxifene acetate
Updated 28-Feb-17
Updated
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Pil
meningococcal Group A, C, W135 and Y conjugate vaccine,
Updated 28-Feb-17
New
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
Pil
meningococcal Group A, C, W135 and Y conjugate vaccine,
Updated 28-Feb-17
Updated
  • Removal of black triangle
SPC
propantheline bromide
Updated 28-Feb-17
Updated
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 10 - Date of revision of the text
SPC
hepatitis a vaccine (inactivated, adsorbed),
Updated 28-Feb-17
Updated
  • Change of distributor
Pil
water for injection, water for injections
Updated 28-Feb-17
Updated
  • Correction of spelling/typing errors
Pil
diclofenac sodium
Updated 28-Feb-17
Updated
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
SPC
folic acid
Updated 28-Feb-17
New
  • New SPC for new product
SPC
diclofenac sodium
Updated 28-Feb-17
Updated
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
SPC
carbocisteine
Updated 28-Feb-17
New
  • New SPC for new product
Pil
decitabine,
Updated 28-Feb-17
Updated
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Pil
bortezomib mannitol boronic ester,
Updated 28-Feb-17
Updated
  • Change to section 6 - date of revision
  • Change to information for healthcare professionals
Pil
insulin aspart
Updated 28-Feb-17
New
  • New PIL for new product
Pil
insulin aspart
Updated 28-Feb-17
New
  • New PIL for new product
Pil
insulin aspart
Updated 28-Feb-17
New
  • New PIL for new product
Pil
simeprevir sodium,
Updated 27-Feb-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 6 - date of revision
SPC
insulin aspart
Updated 27-Feb-17
New
  • New SPC for new product
SPC
brivaracetam,
Updated 27-Feb-17
Updated
  • Change to section 4.8 - Undesirable effects - how to report a side effect
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 10 - Date of revision of the text
Pil
dexamethasone sodium phosphate
Updated 27-Feb-17
Updated
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
SPC
calcium carbonate, calcium lactate gluconate,
Updated 27-Feb-17
Updated
  • Change to section 4.8 - Undesirable effects - how to report a side effect
SPC
prednisolone sodium phosphate
Updated 27-Feb-17
New
  • New SPC for new product
SPC
brivaracetam,
Updated 27-Feb-17
Updated
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 10 - Date of revision of the text
SPC
brivaracetam,
Updated 27-Feb-17
Updated
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 10 - Date of revision of the text
Pil
duloxetine hydrochloride,
Updated 27-Feb-17
Updated
  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision
SPC
midazolam hydrochloride,
Updated 27-Feb-17
Updated
  • Change to section 2 - Qualitative and quantitative composition
Pil
brivaracetam,
Updated 27-Feb-17
Updated
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Pil
brivaracetam,
Updated 27-Feb-17
Updated
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Pil
brivaracetam,
Updated 27-Feb-17
Updated
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
SPC
bendroflumethiazide, bendrofluazide
Updated 27-Feb-17
New
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
SPC
apixaban,
Updated 27-Feb-17
Updated
  • Change to section 4.2 - Posology and method of administration
  • Change to section 9 - Date of first authorisation/renewal of the authorisation
  • Change to section 10 - Date of revision of the text
SPC
bevacizumab
Updated 27-Feb-17
Updated
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 10 - Date of revision of the text
SPC
paracetamol, codeine phosphate hemihydrate
Updated 27-Feb-17
Updated
  • Change to section 6.5 - Nature and contents of container
Pil
carbocisteine
Updated 27-Feb-17
New
  • New PIL for new product
Pil
prednisolone sodium phosphate
Updated 27-Feb-17
New
  • New PIL for new product
Pil
calcium carbonate, calcium lactate gluconate,
Updated 27-Feb-17
Updated
  • Change to section 4 - how to report a side effect
SPC
paracetamol, phenylephrine hydrochloride
Updated 27-Feb-17
Updated
  • Change to section 4.2 - Posology and method of administration
Pil
carbocisteine
Updated 27-Feb-17
New
  • New PIL for new product
SPC
levetiracetam
Updated 27-Feb-17
Updated
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 9 - Date of first authorisation/renewal of the authorisation
  • Change to section 10 - Date of revision of the text
Pil
pramocaine hydrochloride, pramoxine, hydrocortisone acetate
Updated 27-Feb-17
Updated
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision
Pil
hepatitis a vaccine (inactivated, adsorbed),
Updated 27-Feb-17
Updated
  • Change in co-marketing arrangement
SPC
disodium clodronate tetrahydrate,
Updated 27-Feb-17
Updated
  • Change to section 7 - Marketing authorisation holder
  • Change to section 10 - Date of revision of the text
Pil
omeprazole
Updated 27-Feb-17
Updated
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Pil
omeprazole
Updated 27-Feb-17
Updated
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Pil
omeprazole
Updated 27-Feb-17
Updated
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
SPC
ispaghula husk
Updated 27-Feb-17
Updated
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 5.3 - Preclinical safety data
SPC
ispaghula husk
Updated 27-Feb-17
Updated
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 5.3 - Preclinical safety data
Pil
acetylsalicylic acid, aspirin
Updated 27-Feb-17
Updated
  • Change to name of medicinal product
  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision
SPC
buprenorphine
Updated 26-Feb-17
New
  • New SPC for new product
SPC
buprenorphine
Updated 26-Feb-17
New
  • New SPC for new product
SPC
buprenorphine
Updated 26-Feb-17
New
  • New SPC for new product

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue